Life Sciences

Amgen changes marketing practices for Aranesp

Pharma Compliance Alert, September 3, 2008

Amgen will no longer offer rebates to oncology clinics for their use of the erythropoiesis-stimulating agent Aranesp, according to a New York Times article.

Post a Comment





Please enter your comment below:


Please enter the text below: